Search by Drug Name or NDC
NDC 76045-0023-30 Glycopyrrolate 0.2 mg/mL Details
Glycopyrrolate 0.2 mg/mL
Glycopyrrolate is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is GLYCOPYRROLATE.
Product Information
| NDC | 76045-0023 |
|---|---|
| Product ID | 76045-023_2d066d8f-6b6f-4cf8-ae9a-b77fe8b2398a |
| Associated GPIs | |
| GCN Sequence Number | 082030 |
| GCN Sequence Number Description | glycopyrrolate/PF SYRINGE 0.6MG/3ML INJECTION |
| HIC3 | J2B |
| HIC3 Description | ANTICHOLINERGICS,QUATERNARY AMMONIUM |
| GCN | 49329 |
| HICL Sequence Number | 039386 |
| HICL Sequence Number Description | GLYCOPYRROLATE/PF |
| Brand/Generic | Generic |
| Proprietary Name | Glycopyrrolate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Glycopyrrolate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 0.2 |
| Active Ingredient Units | mg/mL |
| Substance Name | GLYCOPYRROLATE |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA214919 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 76045-0023-30 (76045002330)
| NDC Package Code | 76045-023-30 |
|---|---|
| Billing NDC | 76045002330 |
| Package | 10 SYRINGE in 1 CARTON (76045-023-30) / 3 mL in 1 SYRINGE (76045-023-00) |
| Marketing Start Date | 2022-04-21 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |